TW201630537A - Agent for increasing probiotic bacteria in animal intestines and method for improving intestinal environment of livestock using the same - Google Patents
Agent for increasing probiotic bacteria in animal intestines and method for improving intestinal environment of livestock using the same Download PDFInfo
- Publication number
- TW201630537A TW201630537A TW104105249A TW104105249A TW201630537A TW 201630537 A TW201630537 A TW 201630537A TW 104105249 A TW104105249 A TW 104105249A TW 104105249 A TW104105249 A TW 104105249A TW 201630537 A TW201630537 A TW 201630537A
- Authority
- TW
- Taiwan
- Prior art keywords
- livestock
- lactobacillus
- feed
- agent
- bacteria
- Prior art date
Links
- 244000144972 livestock Species 0.000 title claims abstract description 54
- 239000006041 probiotic Substances 0.000 title claims abstract description 37
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 37
- 241001465754 Metazoa Species 0.000 title claims abstract description 29
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 25
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 16
- 210000000936 intestine Anatomy 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 13
- 241000894006 Bacteria Species 0.000 title abstract description 37
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 25
- 239000000194 fatty acid Substances 0.000 claims abstract description 25
- 229930195729 fatty acid Natural products 0.000 claims abstract description 25
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims abstract description 18
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000005639 Lauric acid Substances 0.000 claims abstract description 9
- -1 fatty acid salt Chemical class 0.000 claims abstract description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 241000186000 Bifidobacterium Species 0.000 claims description 8
- 229960002446 octanoic acid Drugs 0.000 claims description 7
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 4
- 159000000007 calcium salts Chemical group 0.000 claims description 3
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 abstract description 7
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 abstract description 4
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 abstract 1
- 125000005313 fatty acid group Chemical group 0.000 abstract 1
- 241000186660 Lactobacillus Species 0.000 description 29
- 229940039696 lactobacillus Drugs 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 13
- 210000003608 fece Anatomy 0.000 description 12
- 241000193468 Clostridium perfringens Species 0.000 description 11
- 241000607142 Salmonella Species 0.000 description 11
- 241000589875 Campylobacter jejuni Species 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 240000001929 Lactobacillus brevis Species 0.000 description 7
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 150000004667 medium chain fatty acids Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 240000006024 Lactobacillus plantarum Species 0.000 description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 description 3
- 238000007403 mPCR Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000214517 Lactobacillus casei group Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282405 Pongo abelii Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
- YBGHFLPNIGPGHX-UHFFFAOYSA-N calcium;octan-1-olate Chemical compound [Ca+2].CCCCCCCC[O-].CCCCCCCC[O-] YBGHFLPNIGPGHX-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Landscapes
- Fodder In General (AREA)
Abstract
Description
本發明係關於一種使腸內存在的益生菌增加的動物腸內益生菌增加劑。此外,本發明係關於一種使用本發明的動物腸內益生菌增加劑,使家畜所具有的腸內菌叢中的益生菌增加且使害菌減少,以改善家畜的腸內環境,因而得以改善與維持消化機能或免疫機能,防範疾病的發生於未然,且改善家畜有效的生產性的家畜腸內環境的改善方法。 本發明中所謂的“動物”,是指哺乳類、鳥類、爬蟲類、兩生類、魚類等的脊椎動物,例如人、家畜、靈長類(猴子、猩猩等)、實驗動物(小鼠、大鼠等)等。此外,本發明中所謂的“家畜”,是指人為了利用其生產物(乳、肉、蛋等)而馴服或飼養的產業動物、寵物或觀賞用的玩賞動物、以及競賽用動物,例如包含牛、豬、綿羊、山羊、馬、家禽、狗、貓、小鳥、養殖魚等。The present invention relates to an intestine probiotic increase agent for an animal which increases the presence of probiotic bacteria in the intestine. Further, the present invention relates to an animal intestinal probiotics increasing agent of the present invention, which increases the probiotic bacteria in the intestinal flora of the livestock and reduces the harmful bacteria to improve the intestinal environment of the livestock, thereby improving A method for improving the intestinal environment of a livestock that maintains digestive function or immune function, prevents the occurrence of disease, and improves the effective productivity of livestock. The term "animal" as used in the present invention refers to a vertebrate such as a mammal, a bird, a reptile, a biogenic, or a fish, such as a human, a domestic animal, a primate (monkey, an orangutan, etc.), an experimental animal (a mouse, a rat). and many more. In addition, the term "livestock" as used in the present invention refers to an industrial animal that is tamed or raised by a person to use its production (milk, meat, eggs, etc.), a pet animal for viewing or watching, and a competition animal, for example, including Cows, pigs, sheep, goats, horses, poultry, dogs, cats, birds, farmed fish, etc.
近年來,由於家畜的大規模飼養型態進一步發展,使個體管理的方式被迫改為群體管理。在此現狀中,由於高飼養密度(頭或隻/面積)的短期飼養、營養或型態不同的飼料的替換、炎熱、寒冷、斷奶、在飼養場人為的群體移動、或是家畜的長距離運送等而使家畜暴露在各種管理壓力中。特別是在夏季,由於地球暖化而造成前所未有的溫度上升,使家畜感受到的壓力顯著增加,另一方面在寒冷季節的壓力也是如此,這些因素給家畜的負面影響不斷增加。那樣的結果,造成疾病發生或成長(體重增加)降低等的生產力降低,以及對於產品品質的影響的重大問題。In recent years, as the large-scale breeding pattern of livestock has been further developed, the way of individual management has been forced to be changed to group management. In this status quo, due to high stocking density (head or area/area) short-term feeding, replacement of different nutrients or different types of feed, hot, cold, weaning, artificial movement in the farm, or long distances of livestock Livestock is exposed to various management pressures, such as transportation. Especially in the summer, the unprecedented temperature rise due to global warming has significantly increased the pressure felt by livestock, and on the other hand, the pressure in the cold season, and the negative impact of these factors on livestock has increased. Such a result causes a decrease in productivity such as a decrease in disease occurrence or growth (weight gain), and a major problem of influence on product quality.
當壓力為降低家畜生產力的間接因素時,可舉出由於消化道等的內臟虛弱化、飼料攝取量降低或營養成分的消化與吸收顯著地降低、腸內菌叢的失衡或免疫力下降,因而容易受到細菌或原蟲等的病原體感染。腸內菌叢包含益生菌及害菌,益生菌可舉出所屬於乳酸桿菌(Lactobacillus)屬或雙叉乳酸桿菌(Bifidobacterium)屬 的細菌等,另一方面害菌可舉出所屬為大腸桿菌(Escherichia Coli)、沙門氏桿菌(Salmonella)屬的細菌、空腸彎曲桿菌(Campylobacter jejuni)、產氣莢膜梭菌(Clostridium perfringens)等的細菌。由於這些益生菌與害菌的競爭性增殖平衡被破壞而形成害菌優勢的腸內菌叢,引起免疫機能下降或消化機能降低,因此被認為是導致疾病的發生或降低生產力的原因。When the pressure is an indirect factor for reducing the productivity of the livestock, it may be due to the weakening of the internal organs such as the digestive tract, the decrease in the feed intake, the significant decrease in the digestion and absorption of the nutrient components, the imbalance of the intestinal flora, or the decrease in immunity. It is susceptible to infection by pathogens such as bacteria or protozoa. The intestinal flora contains probiotics and harmful bacteria, and the probiotics include bacteria belonging to the genus Lactobacillus or Bifidobacterium, and on the other hand, the bacterium is Escherichia coli ( Escherichia Coli), bacteria of the genus Salmonella, Campylobacter jejuni, Clostridium perfringens, and the like. Since the competitive proliferation balance of these probiotics and harmful bacteria is destroyed to form an intestinal flora which is dominant in bacteria, causing a decrease in immune function or a decrease in digestive function, it is considered to be a cause of disease occurrence or a decrease in productivity.
作為對於受到壓力的家畜的處理方法,已公開了例如含有高級脂肪酸三酸甘油酯及中鏈脂肪酸三酸甘油酯的家畜用營養補充劑(專利文獻1)、含有動植物性油脂與食物纖維,目的為改善幼畜的腹瀉、軟便以及減輕壓力的幼畜用代用乳組合物(專利文獻2),主成分包含脫脂奶粉及/或豆粕,且含有中鏈脂肪酸或其鹽類的幼畜用代用乳組合物(專利文獻3),或是包含中鏈脂肪酸混合物,而用於抑制大腸菌的汙染等的藥品(專利文獻4)等。For the treatment of livestock subjected to stress, for example, a nutritional supplement for livestock containing high-grade fatty acid triglyceride and medium-chain fatty acid triglyceride (Patent Document 1), and animal-to-plant fats and food fibers are disclosed. A substitute milk composition for young animals for improving diarrhea, soft stool and stress reduction of young animals (Patent Document 2), a substitute milk for young animals containing a non-fat milk powder and/or soybean meal and containing a medium-chain fatty acid or a salt thereof The composition (Patent Document 3) or a drug containing a medium-chain fatty acid mixture and used for suppressing contamination of coliforms (Patent Document 4).
〔先前技術文獻〕 〔專利文獻〕 〔專利文獻1〕特開平6-153812號公報 〔專利文獻2〕特開平10-127232號公報 〔專利文獻3〕特許第2723961號公報 〔專利文獻4〕特許第5259905號公報[PRIOR ART DOCUMENT] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. Bulletin 5259905
〔發明所欲解決之課題〕 然而,因為只有補充高級脂肪酸三酸甘油酯及中鏈脂肪酸三酸甘油酯,或是只有與食物纖維並用的情況下,至家畜活力提升為止需要較多時間,所以給予了病原體感染的時間,致使改善生產力降低變得困難。而且,若不能改善由於營養上、飼養管理上及飼養環境上的壓力所引起生物調整功能或免疫機能下降,並且修復腸道黏膜,特別是絨毛等時,會有無法期待充分的成長、飼料效率等的生產力的改善,或是腹瀉等疾病發生的改善等的問題點。此外,雖然中鏈脂肪酸的混合物亦具有營養補充效果或腸內大腸菌的抑制效果,但是關於其他害菌的抑制或給予雙叉桿菌等的益生菌的影響尚未知曉。[Problems to be Solved by the Invention] However, since it is only necessary to supplement the higher fatty acid triglyceride and the medium chain fatty acid triglyceride, or only in combination with the dietary fiber, it takes a lot of time until the livestock activity is improved, so The time it takes to infect a pathogen makes it difficult to improve productivity. Moreover, if it is not possible to improve the biological adjustment function or immune function caused by stress in nutrition, feeding management and feeding environment, and repair intestinal mucosa, especially fluff, etc., there will be no expectation of sufficient growth and feed efficiency. Such as the improvement of productivity, or the improvement of diseases such as diarrhea. Further, although the mixture of medium-chain fatty acids also has a nutritional supplement effect or an inhibitory effect on intestinal coliforms, the effects of inhibition of other pests or administration of probiotics such as bifidobacteria are not known.
本發明的目的是著眼於上述一系列的情況,以改善家畜等動物的腸內環境,因而防範疾病的發生於未然,使家畜的生產力提升。The object of the present invention is to improve the intestinal environment of animals such as livestock by focusing on the above-mentioned series of situations, thereby preventing the occurrence of diseases and improving the productivity of livestock.
〔解決課題之手段〕 為了解決上述課題,本發明者等專心研討的結果,發現特定的酸或其鹽類能使家畜等動物的腸內菌叢中的益生菌增加且使害菌降低,以改善腸內環境,防止疾病的發生或生產力降低,而完成了本發明。[Means for Solving the Problem] In order to solve the problem, the present inventors have found that a specific acid or a salt thereof can increase probiotics in the intestinal flora of animals such as livestock and reduce the number of harmful bacteria. The present invention has been completed by improving the intestinal environment, preventing the occurrence of disease or reducing productivity.
也就是說,本發明的動物腸內益生菌增加劑,是含有選自辛酸、癸酸以及月桂酸所組成的群組中的至少一種的脂肪酸或脂肪酸鹽。 此外,本發明的家畜腸內環境的改善方法,是給予家畜調配了0.1~2重量%的本發明的動物腸內益生菌增加劑的飼料。That is, the animal intestinal probiotic increase agent of the present invention is a fatty acid or a fatty acid salt containing at least one selected from the group consisting of caprylic acid, citric acid, and lauric acid. Further, the method for improving the intestinal environment of the livestock of the present invention is to provide the livestock with 0.1 to 2% by weight of the feed of the enteric probiotics increasing agent of the animal of the present invention.
〔發明效果〕 動物腸道內中存在著大量的細菌群而形成腸內菌叢。本發明的動物腸內益生菌增加劑能使家畜等動物的腸內菌叢中的益生菌增加且使害菌降低,以將動物的腸內環境改善成益生菌優勢的菌叢,防止疾病的發生於未然,而提升生產力。而且,主成分的辛酸、癸酸以及月桂酸是原本吸收速度及代謝速度極快速的物質,因此在攝取後能迅速得到活力的方面也是很有效的。 此外,本發明的家畜腸內環境的改善方法能改善家畜的腸內環境、防止疾病的發生於未然,而提升生產力。[Effect of the Invention] A large number of bacterial groups are present in the intestinal tract of an animal to form intestinal flora. The animal enteric probiotics increasing agent of the present invention can increase the probiotics in the intestinal flora of animals such as livestock and reduce the harmful bacteria, thereby improving the intestinal environment of the animal into a probiotic-promoting flora and preventing diseases. It happens before it increases productivity. Further, the main components of octanoic acid, citric acid, and lauric acid are substances which are extremely fast in absorption rate and metabolic rate, and therefore are effective in quickly obtaining vitality after ingestion. Further, the method for improving the intestinal environment of the livestock of the present invention can improve the intestinal environment of the livestock, prevent the occurrence of the disease, and increase the productivity.
以下將對本發明進行詳細的說明。 本發明的動物腸內益生菌增加劑(以下簡稱為“益生菌增加劑”)是包含選自辛酸、癸酸以及月桂酸所組成的群組中的至少一種的脂肪酸或其鹽(以下簡稱為“脂肪酸等”)。較佳為包含選自辛酸、癸酸以及月桂酸所組成的群組中的兩種脂肪酸或其鹽,特佳為含有這些三種的脂肪酸或其鹽。The invention will be described in detail below. The enteric probiotics increasing agent for animals of the present invention (hereinafter referred to as "probiotic increase agent") is a fatty acid or a salt thereof (hereinafter referred to as "a probiotic extracting agent" selected from the group consisting of caprylic acid, capric acid, and lauric acid. "Fatty acids, etc."). It is preferred to contain two kinds of fatty acids or salts thereof selected from the group consisting of caprylic acid, capric acid, and lauric acid, and particularly preferably those containing these three kinds of fatty acids or salts thereof.
上述脂肪酸鹽類從對家畜的必須礦物質成分的觀點而言,以上述的各種脂肪酸的鈣鹽與鎂鹽較為適合,其可以使用一種,亦可將兩種組合使用。利用這些脂肪酸的金屬鹽類在常溫下為固體,容易處理且容易與飼料混合的方面,並考慮到對於反芻動物的瘤胃的影響,在脂質之中較佳為這些脂肪酸金屬鹽。特別是使用固體粉末狀或顆粒狀的脂肪酸鈣或脂肪酸鎂較佳。The fatty acid salt is preferably a calcium salt or a magnesium salt of the above various fatty acids from the viewpoint of essential mineral components of livestock, and may be used singly or in combination of two. The metal salts of these fatty acids are solid at room temperature, are easy to handle, and are easily mixed with the feed, and in view of the rumen effect on ruminants, these fatty acid metal salts are preferred among the lipids. In particular, it is preferred to use a solid powdered or granulated fatty acid calcium or fatty acid magnesium.
本發明的益生菌增加劑能適用在牛、豬、雞等家畜,例如在高飼養密度(頭或隻/面積)的短期飼養、營養或型態不同的飼料的替換、炎熱、寒冷、斷奶、在飼養場人為的群體移動、或是家畜的長距離運送等而使家畜受到各種管理壓力的時期中,由於使腸內的害菌減少、使益生菌增加,因而能防止疾病於未然、促進飼料攝取量的維持或成長,以維持生產力。The probiotic increase agent of the invention can be applied to livestock such as cattle, pigs and chickens, for example, short-term feeding, high-density (head or only/area), replacement of feeds with different nutrition or type, hot, cold, weaning, In the period when the livestock are subjected to various management pressures such as the artificial movement of the farms or the long-distance transportation of livestock, the bacteria in the intestines are reduced and the probiotics are increased, so that the disease can be prevented and the feed can be promoted. Maintain or grow up to maintain productivity.
本發明的益生菌增加劑藉由家畜用飼料(以下亦稱為本發明的家畜用飼料)的給予而能減少的害菌,例如可舉出大腸桿菌、沙門氏桿菌屬、產氣莢膜梭菌等,特別是對於大腸桿菌、產氣莢膜梭菌顯示有較強的效果。此外,藉由本發明的家畜用飼料的給予而能增加的益生菌,例如可舉出屬於乳酸桿菌屬或雙叉乳酸桿菌屬的細菌等。The probiotics-increasing agent of the present invention can be reduced by the administration of a feed for livestock (hereinafter also referred to as a feed for livestock of the present invention), and examples thereof include Escherichia coli, Salmonella, and a gas-producing capsule. Bacteria, etc., especially for Escherichia coli and Clostridium perfringens, have a strong effect. In addition, examples of the probiotic which can be increased by the administration of the feed for livestock of the present invention include bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium.
本發明的益生菌增加劑係可含有載體、賦形劑等的已知添加劑。本發明益生菌增加劑中的上述脂肪酸等的含量較佳為70重量%以上,更佳為90重量%以上,特佳為95重量%以上。當含量未達70重量%時,可能有不能充分改善動物的腸內菌叢的情況,並需給予長鏈脂肪酸或礦物質等其他成分而效率較低。The probiotic enhancer of the present invention may contain known additives such as carriers, excipients and the like. The content of the above fatty acid or the like in the probiotic increase agent of the present invention is preferably 70% by weight or more, more preferably 90% by weight or more, and particularly preferably 95% by weight or more. When the content is less than 70% by weight, there may be a case where the intestinal flora of the animal is not sufficiently improved, and other components such as long-chain fatty acids or minerals are required to be inefficient.
本發明的益生菌增加劑以及家畜用飼料能作為食品添加劑、醫藥品,亦能作為家畜用飼料添加劑使用。 家畜用飼料可包含例如玉米粉、米粉、米糠等的榖粉、無機物、胺基酸、蛋白質、維他命類、脂質等。例如,可包含由日本標準飼料成分表(2009年出版,獨立行政法人 農業、食品產業技術總和研究機構編)中所記載的成分。 本發明的益生菌增加劑以及家畜用飼料的型態,可為液狀、膏狀、粉狀、粒狀、丸狀等任意一種型態,且能依據所需要的型態使用已知的方法來調製。The probiotic increase agent and the livestock feed of the present invention can be used as a food additive or a pharmaceutical product, and can also be used as a feed additive for livestock. The feed for livestock may contain meal such as corn flour, rice flour, rice bran, etc., inorganic substances, amino acids, proteins, vitamins, lipids and the like. For example, it may be included in the ingredients described in the Japan Standard Feed Ingredients Table (published in 2009, edited by the Independent Administrative Corporation Agriculture, Food Industry Technology General Research Institute). The type of the probiotic increase agent and the feed for livestock of the present invention may be any one of a liquid form, a paste form, a powder form, a granular form, a pellet form, and the like, and a known method can be used depending on the desired form. To modulate.
在本發明的家畜腸內環境的改善方法為給予家畜調配了0.1~2重量%,較佳為0.10~1.5重量%,特佳為0.5~1重量%的本發明的益生菌增加劑的飼料。對家畜的給予量在飼料中未達0.1重量%時,可能無法得到本發明的效果。 此外,調配了本發明的益生菌增加劑的飼料的給予頻率或給予量能根據飼料的物理性質、家畜的種類或體重(年齡)等而異,採用該飼料通常的給予頻率或給予量。In the method for improving the intestinal environment of the livestock of the present invention, the livestock is formulated with 0.1 to 2% by weight, preferably 0.10 to 1.5% by weight, particularly preferably 0.5 to 1% by weight, of the feed of the probiotics increasing agent of the present invention. When the amount of livestock administered is less than 0.1% by weight in the feed, the effects of the present invention may not be obtained. Further, the frequency of administration or the amount of administration of the feed to which the probiotic increase agent of the present invention is formulated can vary depending on the physical properties of the feed, the type of livestock, or the body weight (age), etc., and the usual frequency or dose of administration of the feed is employed.
〔實施例〕 以下雖然根據實施例對本發明進行更詳細的說明,但本發明在不超過其要旨之下不以此為限。[Embodiment] Hereinafter, the present invention will be described in more detail based on the examples, but the present invention is not limited thereto.
作為實施例使用的家畜用飼料,準備了四種的辛酸鈣、癸酸鈣、月桂酸鈣、辛酸/癸酸/月桂酸混合脂肪酸鈣的家畜用飼料。此外,“辛酸/癸酸/月桂酸混合脂肪酸鈣”是由辛酸:癸酸:月桂酸=20:20:60(重量比)所形成的混合脂肪酸的鈣鹽,且為油化產業公司製的商品。家畜用飼料的脂肪酸含量如表1所示。As a feed for livestock used in the examples, four kinds of livestock feeds of calcium octylate, calcium citrate, calcium laurate, and caprylic/capric acid/lauric acid mixed fatty acid calcium were prepared. In addition, "octanoic acid/capric acid/lauric acid mixed fatty acid calcium" is a calcium salt of a mixed fatty acid formed of octanoic acid: citric acid: lauric acid = 20:20:60 (weight ratio), and is made by the oil chemical industry company. commodity. The fatty acid content of livestock feed is shown in Table 1.
【表1】 實施例中使用的家畜用飼料的脂肪酸含量
〔實施例1~5、比較例1~5〕 將水以及如表2所示的基礎飼料進行飽食給予的50頭荷蘭乳牛,在各個實施例及比較例中各使用5頭,並給予表3及表4所示的家畜用飼料3週。給予3週後進行糞便採樣,並冷凍保存直到進行分析。糞便中細菌數是利用即時定量PCR方法調查了雙叉乳酸桿菌屬、大腸桿菌、沙門氏桿菌屬、空腸彎曲桿菌、產氣莢膜梭菌。具體而言,是根據1.自檢體抽出DNA;2.使用該DNA以各PCR方法進行分析;3.基於基因量與細菌數的比例關係定量出細菌數;的步驟求得細菌數。接著,將給予前的細菌數作為1以計算出相對值。此外,利用多重PCR進行糞便中9種乳酸桿菌屬的細菌,亦即,嗜酸乳酸桿菌(Lactobacillus acidophilus)、酪蛋白乳酸桿菌群(Lactobacillus casei-group)、戴白氏乳酸桿菌(Lactobacillus delbrueckii)、加氏乳酸桿菌(Lactobacillus gasseri)、胚芽乳酸桿菌(Lactobacillus plantarum)、雷曼氏乳桿菌(Lactobacillus rhamnosus)、洛德因乳酸桿菌(Lactobacillus reuteri)的檢測。此外更調查了在給予期間中的腹瀉的發生率、給予3週後的產乳量、乳脂肪率、乳蛋白質率。各實施例的結果分別如表5、表7、表9及表10所示,各比較例的結果分別如表6、表8、表9及表10所示。[Examples 1 to 5, Comparative Examples 1 to 5] 50 Dutch dairy cows, which were fed with water and the basal feed as shown in Table 2, were used in each of the Examples and Comparative Examples, and given Table 3 And the livestock feed shown in Table 4 for 3 weeks. Fecal samples were taken 3 weeks later and stored frozen until analysis. The number of bacteria in the feces was investigated by real-time quantitative PCR method for Lactobacillus, Escherichia coli, Salmonella, Campylobacter jejuni, Clostridium perfringens. Specifically, the DNA is extracted according to 1. The self-test body is extracted; 2. The DNA is analyzed by each PCR method; 3. The number of bacteria is quantified based on the proportional relationship between the amount of the gene and the number of bacteria; Next, the number of bacteria before administration was taken as 1 to calculate a relative value. In addition, multiplex PCR is used to carry out nine Lactobacillus bacteria in the feces, that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Detection of Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri. In addition, the incidence of diarrhea during the administration period, the amount of milk produced after 3 weeks of administration, the milk fat percentage, and the milk protein ratio were investigated. The results of the respective examples are shown in Tables 5, 7, 7, and 10, and the results of the respective comparative examples are shown in Table 6, Table 8, Table 9, and Table 10, respectively.
【表2】 基礎飼料的調配比例
【表3】 在基礎飼料的家畜用飼料添加量
【表4】
【表5】
【表6】
【表7】
【表8】
【表9】
【表10】
如表5所示,給予了本發明的實施例1~5的益生菌增加劑的牛的糞便中,雙叉乳酸桿菌屬的細菌数是增加至未給予牛的1.02倍至1.18倍,大腸桿菌為減少0.77倍至0.16倍,產氣莢膜梭菌為減少0.89倍至0.70倍。 另一方面,如表6所示,比較例1~5中的雙叉乳酸桿菌屬以及大腸桿菌沒有太大的增減,產氣莢膜梭菌則最多增加至1.22倍。相對於實施例1~5中的沙門氏桿菌屬的細菌数為0.98倍至0.93倍而沒有太大的變化,且空腸彎曲桿菌為1.13倍~1.16倍而顯示為稍微增加,比較例1~5中的沙門氏桿菌屬為1.01~1.10倍、空腸彎曲桿菌為1.17~1.26倍,可以得知實施例中抑制了兩者細菌數的增加。As shown in Table 5, in the feces of cattle to which the probiotics increasing agents of Examples 1 to 5 of the present invention were administered, the number of bacteria of the genus Bifidobacterium was increased from 1.02 to 1.18 times that of the unadministered bovine, Escherichia coli In order to reduce 0.77 times to 0.16 times, Clostridium perfringens was reduced by 0.89 times to 0.70 times. On the other hand, as shown in Table 6, the Lactobacillus brevis and the Escherichia coli in Comparative Examples 1 to 5 did not increase or decrease much, and the Clostridium perfringens increased by a maximum of 1.22 times. The number of bacteria in the genus Salmonella in Examples 1 to 5 was 0.98 to 0.93 times without much change, and Campylobacter jejuni was 1.13 to 1.16 times and showed a slight increase, Comparative Examples 1 to 5 In the case of Salmonella in the range of 1.01 to 1.10 times and Campylobacter jejuni in the range of 1.17 to 1.26 times, it is known that the increase in the number of bacteria in both cases is inhibited.
如表7所示,在實施例1~5的糞便中檢測出乳酸桿菌屬的頭數比例,酪蛋白乳酸桿菌群為20%~40%,加氏乳酸桿菌為40%~60%。 另一方面,如表8所示,在比較例1~5中,沒有檢測出任一種細菌的個體。As shown in Table 7, the number of heads of the genus Lactobacillus was detected in the feces of Examples 1 to 5, and the Lactobacillus casei group was 20% to 40%, and the Lactobacillus bergii was 40% to 60%. On the other hand, as shown in Table 8, in Comparative Examples 1 to 5, no individual of any kind of bacteria was detected.
此外,如表9所示的實施例1~5的腹瀉發生率為0~20%。 另一方面,比較例1~5則為40~80%,與實施例1~5相比腹瀉發生率較高。Further, the incidence of diarrhea in Examples 1 to 5 as shown in Table 9 was 0 to 20%. On the other hand, Comparative Examples 1 to 5 were 40 to 80%, and the incidence of diarrhea was higher than those of Examples 1 to 5.
如表10所示的實施例1~5為高達37~39kg/日的產乳量。 另一方面,比較例1~5則為33~35kg/日,與實施例1~5相比產乳量較低。Examples 1 to 5 shown in Table 10 are milk yields as high as 37 to 39 kg/day. On the other hand, Comparative Examples 1 to 5 were 33 to 35 kg/day, and the amount of milk produced was lower than those of Examples 1 to 5.
〔實施例6~10、比較例6~10〕 將水以及如表11所示的基礎飼料進行飽食給予的50頭的LWD種去勢仔豬,在各個實施例及比較例中各使用5頭,並給予表12及表13所示的家畜用飼料2週。給予2週後進行糞便採樣,並冷凍保存直到進行分析。糞便中細菌數是利用即時定量PCR方法調查了雙叉乳酸桿菌屬、大腸桿菌、沙門氏桿菌屬、空腸彎曲桿菌、產氣莢膜梭菌。具體而言,是根據1.自檢體抽出DNA;2.使用該DNA以各PCR方法進行分析;3.基於基因量與細菌數的比例關係定量出細菌數;的步驟求得細菌數。接著,將給予前的豬的細菌數作為1以計算出相對值。此外,利用多重PCR進行糞便中9種乳酸桿菌屬的細菌,亦即,嗜酸乳酸桿菌、酪蛋白乳酸桿菌群、戴白氏乳酸桿菌、加氏乳酸桿菌、胚芽乳酸桿菌、雷曼氏乳桿菌、洛德因乳酸桿菌的檢測。此外更調查了在給予期間中的腹瀉的發生率、以及從給予2週的飼料攝取量與體重計算出飼料效率。各實施例的結果分別如表14、表16、表18及表19所示,各比較例的結果分別如表15、表17、表18及表19所示。[Examples 6 to 10, Comparative Examples 6 to 10] 50 LWD seed castlets to which water and a basal feed as shown in Table 11 were satiety-fed were used, and 5 heads were used in each of the examples and the comparative examples, and The livestock feeds shown in Table 12 and Table 13 were given for 2 weeks. Fecal samples were taken 2 weeks later and stored frozen until analysis. The number of bacteria in the feces was investigated by real-time quantitative PCR method for Lactobacillus, Escherichia coli, Salmonella, Campylobacter jejuni, Clostridium perfringens. Specifically, the DNA is extracted according to 1. The self-test body is extracted; 2. The DNA is analyzed by each PCR method; 3. The number of bacteria is quantified based on the proportional relationship between the amount of the gene and the number of bacteria; Next, the number of bacteria in the pig before administration was taken as 1 to calculate a relative value. In addition, multiplex PCR is used to carry out 9 strains of Lactobacillus in the feces, that is, Lactobacillus acidophilus, Lactobacillus casein, Lactobacillus brevis, Lactobacillus bergii, Lactobacillus plantarum, Lactobacillus reh. , Loder because of the detection of lactobacilli. In addition, the incidence of diarrhea during the administration period and the feed efficiency from the two-week feed intake and body weight were further investigated. The results of the respective examples are shown in Table 14, Table 16, Table 18, and Table 19, and the results of the respective comparative examples are shown in Table 15, Table 17, Table 18, and Table 19, respectively.
【表11】 基礎飼料的調配比例
【表12】
【表13】
【表14】
【表15】
【表16】
【表17】
【表18】
【表19】
如表14所示,在實施例6~10中,糞便中的雙叉乳酸桿菌屬增加至1.16倍~1.35倍,大腸桿菌為減少0.79倍~0.26倍,沙門氏桿菌屬為減少0.84倍~0.21倍,空腸彎曲桿菌為減少0.88倍~0.60倍,產氣莢膜梭菌為減少0.89倍~0.66倍。 另一方面,如表15所示,在比較例6~10的情況下,雙叉乳酸桿菌屬為0.93~1.00倍而沒有太大的變化,大腸桿菌為1.00倍~1.11倍,沙門氏桿菌屬為增加至1.05倍~1.16倍,空腸彎曲桿菌為增加至1.15~1.27倍,且產氣莢膜梭菌為增加至1.08~1.29倍。As shown in Table 14, in Examples 6 to 10, the Lactobacillus in the feces increased from 1.16 to 1.35 times, the Escherichia coli was reduced by 0.79 to 0.26 times, and the Salmonella was decreased by 0.84 to 0.21. Times, Campylobacter jejuni was reduced by 0.88 to 0.60 times, and Clostridium perfringens was reduced by 0.89 to 0.66 times. On the other hand, as shown in Table 15, in the case of Comparative Examples 6 to 10, the genus Bifidobacterium was 0.93 to 1.00 times without much change, and Escherichia coli was 1.00 to 1.11 times, and Salmonella was In order to increase to 1.05 times to 1.16 times, Campylobacter jejuni increased to 1.15 to 1.27 times, and Clostridium perfringens increased to 1.08 to 1.29 times.
如表16所示,在實施例6~10的糞便中檢測出乳酸桿菌屬的頭數比例(檢出率),嗜酸乳酸桿菌為40%~60%,戴白氏乳酸桿菌為20%~80%,加氏乳酸桿菌為60%~80%,雷曼氏乳桿菌為40%~60%。 另一方面,如表17所示,在比較例6~10中的嗜酸乳酸桿菌為0%~20%,戴白氏乳酸桿菌為0%~20%,加氏乳酸桿菌為0%~20%,雷曼氏乳桿菌為0%~20%,因此檢出率較低,且沒有檢測出其他的細菌。As shown in Table 16, the number of heads of Lactobacillus (detection rate) was detected in the feces of Examples 6 to 10, 40% to 60% of Lactobacillus acidophilus, and 20% of Lactobacillus pallidum. 80%, Lactobacillus bergii is 60% to 80%, and Lactobacillus brevis is 40% to 60%. On the other hand, as shown in Table 17, the Lactobacillus acidophilus in Comparative Examples 6 to 10 was 0% to 20%, the Lactobacillus bacillus was 0% to 20%, and the Lactobacillus kawaii was 0% to 20%. %, Lactobacillus brevis is 0% to 20%, so the detection rate is low, and no other bacteria are detected.
此外,如表18所示的實施例6~10的腹瀉發生率為0~20%。 另一方面,比較例6~10為40~80%,與實施例6~10相比腹瀉發生率較高。Further, the incidence of diarrhea in Examples 6 to 10 as shown in Table 18 was 0 to 20%. On the other hand, Comparative Examples 6 to 10 were 40 to 80%, and the incidence of diarrhea was higher than that of Examples 6 to 10.
此外,如表19所示的實施例6~10的飼料效率高達0.81~0.84。 另一方面,比較例6~10為0.77~0.79,與實施例6~10相比飼料效率較低。Further, the feed efficiencies of Examples 6 to 10 as shown in Table 19 were as high as 0.81 to 0.84. On the other hand, Comparative Examples 6 to 10 were 0.77 to 0.79, and the feed efficiency was lower than those of Examples 6 to 10.
〔實施例11~15、比較例11~15〕 將水以及如表20所示的基礎飼料進行飽食給予的1000隻3週齡的肉雞,在各個實施例及比較例中各使用100隻,並給予表21及表22所示的家畜用飼料5週。給予5週後,從各區中的5隻分別進行糞便採樣,並以冷凍保存直到分析。糞便中細菌數是利用即時定量PCR方法調查了雙叉乳酸桿菌屬、大腸桿菌、沙門氏桿菌屬、空腸彎曲桿菌、產氣莢膜梭菌。具體而言,是根據1.自檢體抽出DNA;2.使用該DNA以各PCR方法進行分析;3.基於基因量與細菌數的比例關係定量出細菌數;的步驟求得細菌數。接著,將給予前的肉雞的細菌數作為1以計算出相對值。此外,利用多重PCR進行糞便中9種乳酸桿菌屬的細菌,亦即,嗜酸乳酸桿菌、酪蛋白乳酸桿菌群、戴白氏乳酸桿菌、加氏乳酸桿菌、胚芽乳酸桿菌、雷曼氏乳桿菌、洛德因乳酸桿菌的檢測。此外也調查5週後的育成率。各實施例的結果分別如表23、表25及表27所示,各比較例的結果分別如表24、表26及表27所示。[Examples 11 to 15 and Comparative Examples 11 to 15] 1000 three-week-old broilers to which water and the basal diet shown in Table 20 were satiety-fed were used, and 100 each were used in each of the examples and the comparative examples, and The livestock feeds shown in Table 21 and Table 22 were given for 5 weeks. After 5 weeks of administration, stool samples were taken from 5 out of each zone and stored frozen until analysis. The number of bacteria in the feces was investigated by real-time quantitative PCR method for Lactobacillus, Escherichia coli, Salmonella, Campylobacter jejuni, Clostridium perfringens. Specifically, the DNA is extracted according to 1. The self-test body is extracted; 2. The DNA is analyzed by each PCR method; 3. The number of bacteria is quantified based on the proportional relationship between the amount of the gene and the number of bacteria; Next, the number of bacteria in the broiler before administration was taken as 1 to calculate a relative value. In addition, multiplex PCR is used to carry out 9 strains of Lactobacillus in the feces, that is, Lactobacillus acidophilus, Lactobacillus casein, Lactobacillus brevis, Lactobacillus bergii, Lactobacillus plantarum, Lactobacillus reh. , Loder because of the detection of lactobacilli. In addition, the breeding rate after 5 weeks was also investigated. The results of the respective examples are shown in Table 23, Table 25, and Table 27, respectively, and the results of the respective comparative examples are shown in Table 24, Table 26, and Table 27, respectively.
【表20】 基礎飼料的調配比例
【表21】
【表22】
【表23】
【表24】
【表25】
【表26】
【表27】
如表23所示,在實施例11~15中,糞便中的雙叉乳酸桿菌屬增加至1.16倍~1.31倍,大腸桿菌為減少0.77倍~0.40倍,沙門氏桿菌屬為減少0.58倍~0.23倍,空腸彎曲桿菌為減少0.80倍~0.63倍,產氣莢膜梭菌為減少0.85倍~0.64倍。 另一方面,如表24所示,在比較例11~15的情況下,雙叉乳酸桿菌屬為0.98~1.01倍而沒有太大的變化,大腸桿菌增加成0.99倍~1.11倍,沙門氏桿菌屬為1.04倍~1.11倍,空腸彎曲桿菌為1.00~1.16倍,且產氣莢膜梭菌為0.99~1.10倍而表示為增加或無太大的變化。As shown in Table 23, in Examples 11 to 15, the Bifidobacterium genus in the feces increased to 1.16 times to 1.31 times, the Escherichia coli decreased by 0.77 times to 0.40 times, and the Salmonella genus decreased by 0.58 times to 0.23. Times, Campylobacter jejuni was reduced by 0.80 to 0.63 times, and Clostridium perfringens was reduced by 0.85 to 0.64 times. On the other hand, as shown in Table 24, in the case of Comparative Examples 11 to 15, the Bifidobacterium genus was 0.98 to 1.01 times without much change, and the Escherichia coli was increased to 0.99 times to 1.11 times, and Salmonella was increased. The genus was 1.04 times to 1.11 times, Campylobacter jejuni was 1.00 to 1.16 times, and Clostridium perfringens was 0.99 to 1.10 times and was expressed as an increase or not.
如表25所示,在實施例11~15的糞便中檢測出乳酸桿菌屬的隻數的比例(檢出率),檢測出嗜酸乳酸桿菌為40%~60%,戴白氏乳酸桿菌為40%~60%,加氏乳酸桿菌為40%~80%,雷曼氏乳桿菌為40%~80%。 另一方面,如表26所示,在比較例11~15中的戴白氏乳酸桿菌為0%~20%,加氏乳酸桿菌為0%~20%,雷曼氏乳桿菌為0%~20%,為檢出率較低,且未檢測出其他的細菌。As shown in Table 25, the ratio of the number of Lactobacillus species (detection rate) was detected in the feces of Examples 11 to 15, and the Lactobacillus acidophilus was detected to be 40% to 60%, and the Lactobacillus pallidum was 40%~60%, Lactobacillus bergii is 40%~80%, and Lactobacillus brevis is 40%~80%. On the other hand, as shown in Table 26, in Comparative Examples 11 to 15, Lactobacillus pallidum was 0% to 20%, Lactobacillus bergii was 0% to 20%, and Lactobacillus brevis was 0%. 20%, the detection rate is low, and no other bacteria are detected.
此外,如表27所示的實施例11~15的育成率為99~100%。 另一方面,在比較例11~15為95~97,與實施例11~15相比育成率較低。Further, the growth rates of Examples 11 to 15 shown in Table 27 were 99 to 100%. On the other hand, in Comparative Examples 11 to 15, the ratio was 95 to 97, and the growth rate was lower than that of Examples 11 to 15.
由於本發明的動物腸內益生菌增加劑能使腸內存在的益生菌增加且使害菌減少,而改善動物的腸內環境,因此能作為食品添加劑、藥品或是家畜用飼料添加劑使用。特別是藉由給予家畜調配了特定量的本發明的動物腸內益生菌增加劑的飼料,能使家畜所具有的腸內菌叢中的益生菌增加且使害菌減少,以改善家畜的腸內環境,因此能防範疾病的發生於未然,提升家畜的生產力。Since the intestine probiotics increasing agent of the present invention can increase the number of probiotics present in the intestine and reduce the number of harmful bacteria, and improve the intestinal environment of the animal, it can be used as a food additive, a medicine or a feed additive for livestock. In particular, by administering a specific amount of the feed of the enteric probiotics increasing agent of the animal of the present invention to the livestock, the probiotics in the intestinal flora of the livestock can be increased and the harmful bacteria can be reduced to improve the intestinal tract of the livestock. The internal environment can prevent the occurrence of diseases and improve the productivity of livestock.
(無)(no)
(無)(no)
無no
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW104105249A TWI663919B (en) | 2015-02-16 | 2015-02-16 | Increasing agent for useful bacteria in animal intestines and livestock intestinal environment improvement method using the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW104105249A TWI663919B (en) | 2015-02-16 | 2015-02-16 | Increasing agent for useful bacteria in animal intestines and livestock intestinal environment improvement method using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201630537A true TW201630537A (en) | 2016-09-01 |
| TWI663919B TWI663919B (en) | 2019-07-01 |
Family
ID=57442883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW104105249A TWI663919B (en) | 2015-02-16 | 2015-02-16 | Increasing agent for useful bacteria in animal intestines and livestock intestinal environment improvement method using the same |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI663919B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115812858A (en) * | 2022-03-15 | 2023-03-21 | 中国农业大学 | Additive and application thereof in improving egg poultry production performance |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001285765A1 (en) * | 2000-06-20 | 2002-01-02 | Nutrition Sciences | Medium chain fatty acids applicable as antimicrobial agents |
-
2015
- 2015-02-16 TW TW104105249A patent/TWI663919B/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115812858A (en) * | 2022-03-15 | 2023-03-21 | 中国农业大学 | Additive and application thereof in improving egg poultry production performance |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI663919B (en) | 2019-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10398156B2 (en) | Animal feed compositions and feed additives | |
| JP6991162B2 (en) | Bacillus subtilis strain showing probiotic activity | |
| JP2021141899A (en) | Feed additive composition | |
| WO2018049657A1 (en) | Healthy nutritious feed for animals | |
| CN107484879A (en) | Feed addictive, antibiotic-free feed and its application | |
| CA3115144A1 (en) | Microbials for animals | |
| CN105410365A (en) | Feed additive capable of replacing antibiotics and application of feed additive | |
| Tesfaye et al. | The effects of probiotics supplementation on milk yield and composition of lactating dairy cows | |
| JP5499231B2 (en) | Animal feed composition containing Lactobacillus plantarum, combined animal feed containing the composition, and method for maintaining or growing the Lactobacillus plantarum in the animal intestine | |
| Dar et al. | Impact of supplementation of probiotic, prebiotic and synbiotic on serum biochemical profile of crossbred calves | |
| JP2025502713A (en) | Use of lactic acid bacteria to inhibit the growth of methanogens and reduce methane emissions | |
| JP2022521576A (en) | Compositions containing Basilaen-producing bacteria or preparations thereof | |
| JP2006254841A (en) | Feed composition containing bifidobacteria growth promoting component and method of use | |
| JP6557686B2 (en) | Animal intestinal useful bacteria increasing agent and livestock intestinal environment improving method using the same | |
| Mohamed et al. | Effect of probiotics supplementation on productive performance of growing lambs | |
| TWI663919B (en) | Increasing agent for useful bacteria in animal intestines and livestock intestinal environment improvement method using the same | |
| KR100857771B1 (en) | Fish feed composition comprising Bacillus polyfermentus, Bacillus rickeniformis and Saccharomyces cervieira | |
| Das et al. | Role of direct fed microbials in enhancing bovine productivity: a review | |
| Ivannikova et al. | Effect of the feed additive ProVetin on the development of foals | |
| Choiri et al. | Effect of Nano-Encapsulation of Noni (Morinda citrifolia) Fruit Extract on Jejunal Morphology and Microbial Populations in Laying Hens | |
| JP2000325027A (en) | Gain-promoter for animal | |
| Alhidary et al. | Effects of direct-fed microbial supplementation on growth performance and metabolic profile of newborn lambs weaned at different ages | |
| Vahedi et al. | Effects of Supplementation of Synbiotic (DiPro Plus) on Growth Performance, Health Status, Skeletal parameters and Blood Parameters in Holstein Suckling Calves. | |
| CN106520614A (en) | Method for improving production performance of Beijing fatty chicken by using neutral protease-producing bacillus coagulans | |
| Tissopi et al. | Effect of Feeding Probiotics and Milk Powder Supplemented Creep Ration on the Growth Performance and Efficiency of Feed Utilization in Pre-weaning Piglets |